Atara Bio (ATRA) has revealed data from the first part of the ongoing Phase 1 study of ATA188 for the treatment of progressive …
Are the tides turning on Wall Street? Stocks fell for a third consecutive session, as investors abandoned the tech heavyweights that have been …
Atara Biotherapeutics Inc (NASDAQ:ATRA) On Monday December 14, 2015 shares of Atara Biotherapeutics tanked 37% after the company reported that a phase 2 …
